Trials / Completed
CompletedNCT07301619
Post-market Study on BtHCROSS® for Restoring Facial Volume After a Single Injection
Post-marketing Clinical Investigation to Evaluate the Efficacy and Safety of BtHCROSS for Restoring Facial Volume and Filling Facial Folds and Wrinkles
- Status
- Completed
- Phase
- N/A
- Study type
- Interventional
- Enrollment
- 203 (actual)
- Sponsor
- i+Med S.Coop. · Industry
- Sex
- All
- Age
- 30 Years – 70 Years
- Healthy volunteers
- Not accepted
Summary
This clinical study investigated the safety and effectiveness of BtHCROSS, a hyaluronic acid-based injectable used to restore facial volume and reduce wrinkles. Adults aged 30 to 70 received a single treatment and were monitored over 9 months. Researchers assessed improvements in facial appearance and recorded any side effects. The results aimed to support the product's continued safe use in aesthetic treatments.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| DEVICE | BtHCROSS® | Single injection of 1 ml of viscoelastic sodium hyaluronate solution crosslinked |
Timeline
- Start date
- 2022-04-26
- Primary completion
- 2023-02-17
- Completion
- 2023-02-17
- First posted
- 2025-12-24
- Last updated
- 2025-12-24
Locations
1 site across 1 country: Spain
Source: ClinicalTrials.gov record NCT07301619. Inclusion in this directory is not an endorsement.